Clinical Trials Logo

Mental Disorders clinical trials

View clinical trials related to Mental Disorders.

Filter by:

NCT ID: NCT03266614 Completed - Loneliness Clinical Trials

"Recovery 4 US" - A Photovoice-based Social Media Program

R4US
Start date: April 7, 2017
Phase: N/A
Study type: Interventional

This study is a randomized trial evaluating "Recovery 4 US", a social media program aimed at the enhancement of community participation and overall recovery of individuals with psychiatric disabilities.This innovative e-mental health program integrates Internet and mobile technologies and is designed to be a self-sustaining recovery-oriented virtual community for individuals living with a disabling mental illness based on the principles of Photovoice.

NCT ID: NCT03264560 Completed - Clinical trials for Psychiatric Disorder

Comparison of Asynchronous Telepsychiatry vs. Synchronous Telepsychiatry in Skilled Nursing Facilities

CATeleST
Start date: June 27, 2017
Phase: N/A
Study type: Interventional

There is a critical shortage of psychiatric services to people with mental illness who live in Skilled Nursing Facilities (SNFs), especially those in rural settings. Although real-time video conferencing psychiatric consultation, termed Synchronous Telepsychiatry (STP), has been around for almost 3 decades, its adaptation is met with logistic and other challenges. In this context, the investigators investigate a novel method of psychiatric consultation termed Asynchronous Telepsychiatry (ATP). The main hypotheses are that that ATP will be as clinically effective as STP, and that it will be acceptable to patients. This study aims to evaluate the comparative clinical effectiveness of ATP vs. STP in SNF population, in a 12-month non-inferiority, randomized, controlled trial.

NCT ID: NCT03260725 Completed - Conduct Disorder Clinical Trials

Evaluating the Feasibility of Internet-delivered PCIT

Start date: April 4, 2011
Phase: N/A
Study type: Interventional

The present study is leveraging a randomized-controlled design to evaluate an Internet-based format for the delivery of Parent-Child Interaction Therapy (I-PCIT). Drawing on videoteleconferencing technology, this format affords real-time interactions for the provision of care traditionally delivered in person, regardless of a family's geographic proximity to a mental health facility. Moreover, drawing on technological innovation to deliver interventions directly to families in their natural settings may extend the ecological validity of PCIT, as treatment is delivered in the very context in which child problems occur. Families seeking treatment for early child disruptive behavior problems (N=40) are being randomly assigned to either receive Internet-delivered PCIT or clinic-based PCIT. Outcomes and feasibility/acceptability will be assessed across the treatment phase as well as at post-treatment and 6-month follow-up.

NCT ID: NCT03255642 Completed - Clinical trials for REM Sleep Behavior Disorder

Efficacy and Safety of Melatonin and Clonazepam for IRBD

Start date: November 9, 2017
Phase: N/A
Study type: Interventional

This study aimed to evaluate influence of melatonin or clonazepam treatment on symptom and polysomnographic parameters in patients with idiopathic REM sleep behavior disorder.

NCT ID: NCT03246789 Completed - Clinical trials for Mental Health Disorder

Reaching and Engaging Depressed Senior Center Clients (REDS)

REDS
Start date: January 1, 2018
Phase: N/A
Study type: Interventional

The purpose of this study is to test the feasibility of two types of group therapy sessions. The research is being done because the researchers are trying to learn if these approaches could be used by therapist in the community social service agencies to treat older adults with depression. There are two study groups. One group is a form of group therapy called "Engage-M", which encourages subjects to engage in physical and social activities that they find pleasurable or rewarding. One group is another form of group therapy called, "Wellness in Mind and Body", which focuses on education and de-stigmatization of health and mental health conditions.

NCT ID: NCT03244787 Completed - Clinical trials for ColoRectal Cancer Screening

Patient Navigation for Colorectal Cancer Screening for Patients With Mental Illness and/or Substance Use Disorder

Start date: January 2017
Phase: N/A
Study type: Interventional

The investigators propose to develop, implement, and evaluate a novel Colorectal (CRC) screening patient navigator program for patients with Mental Health (MH) and /or Substance Use Disorder (SUD) receiving care at Massachusetts General Hospital Charlestown. The study will involve randomly assigning eligible patients to early intervention or usual care/delayed intervention groups. The investigators believe this random assignment is ethical because Patient Navigation (PN) is an extremely limited resource, and all patients identified as eligible could not be contacted by the navigators in a short period of time. Thus the investigators will randomly assign access to PN during the study period, and then allow all patients to be navigated and screened after the study period is over. As a result, all eligible patients will be referred for PN, but the timing of the referral will be randomly assigned.

NCT ID: NCT03235908 Completed - Bipolar Disorder Clinical Trials

Copeptin in Outcome Prediction of an Acute Psychotic Episode

CoPsych
Start date: May 1, 2017
Phase:
Study type: Observational

An acute psychotic episode is a severe psychiatric syndrome which might occur in different psychiatric diagnoses. The outcome prediction of relapse rate of a psychotic episode within a certain time frame is difficult and depends on many factors. More and better predictors are required to improve the outcome prediction in order to adjust therapy and follow-up if patients suffer from this acute disease. Copeptin, a surrogate marker for vasopressin, has been proven helpful in the prediction of the outcome in serious somatic diseases. Additionally, a rise of copeptin due to psychological stress was shown. The aim of this study is to investigate the association of the neuroendocrine biomarker copeptin and the prediction of the onset of psychotic episode within one year.

NCT ID: NCT03231761 Completed - Depression Clinical Trials

Impact of Video Presentations on Medical Students' Attitudes Toward Mental Illness

Start date: August 21, 2017
Phase: N/A
Study type: Interventional

This is a randomized controlled trial examining the impact of videos on medical students' implicit and explicit attitudes and knowledge related to mental illness in Nepal. Medical students are randomized to one of three conditions: (a) no video, (b) a didactic video based on the mental health Gap Action Programme (mhGAP) modules for depression and psychosis; and (c) videos with personal testimonials from mental health service users with depression and psychosis.

NCT ID: NCT03230955 Completed - Smoking Cessation Clinical Trials

Effectiveness of a Smoking Cessation Quit Line for Mental Health Patients

QUITMENTAL
Start date: May 2, 2017
Phase: N/A
Study type: Interventional

Pragmatic randomized clinical trial, single-blind, with allocation 2:1 [Intervention Group (IG) and control group (CG)] in 5 acute hospitals. The IG will receive telephone assistance to quit smoking (including psychological and psycho-educational support and pharmacological treatment advice, if required) proactively for 12 months, and the CG only brief counselling after discharge. To assess the effectiveness of a multicomponent and motivational intensive telephone-based intervention to stop smoking ("quit line") addressed to smokers with mental disorders discharged from hospitals.

NCT ID: NCT03228394 Completed - Depression Clinical Trials

A Clinical Trial of Intravenous (IV) Ganaxolone in Women With Postpartum Depression

Start date: June 27, 2017
Phase: Phase 2
Study type: Interventional

This study will evaluate the Safety, Pharmacokinetics and Efficacy of IV Administration of Ganaxolone in Women with Postpartum Depression